Loading...
Please wait, while we are loading the content...
Dexmedetomidine Premix Formulation I. Field of the Invention
| Content Provider | Semantic Scholar |
|---|---|
| Author | Cedergren, Robert A. Polansky, Gregg |
| Copyright Year | 2017 |
| Abstract | FORMULATION “Dexmedetomidine HCL Draft Labeling: PrecedexTM Dexmedetomidine Hydrochloride Injection.” FDA approved label, (75) Inventors: Priyanka Roychowdhury, San Rafael, dated Dec. 17, 1999, and available online Jul. 26, 2001, pp. 1-13. CA (US); Robert A. Cedergren, Libertyville, IL (US) Downloaded from ( http://www.accessdata.fda.gov/drugsatfla s docs/nda'99/21-038 Precedex printlbl.pdf> on Jan. 4, 2012. (73) Assignee: Hospira, Inc., Lake Forest, IL (US) FDA Memorandum from Cynthia G. McCormick, M.D., Director, Divison on Anesthetics, Critical Care and Addiction Drug Products, dated Nov.30, 1999, in connection with the Medical Reviews of the Precedes (dexmedetomidine hydrochloride injection) Application patent is extended or adjusted under 35 No. 21-038 submitted to the FDA by Abbott Laboratories on Dec. 18, (*) Notice: Subject to any disclaimer, the term of this |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | https://patentimages.storage.googleapis.com/86/63/06/858cb8fe919ef6/US8242158.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |